Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
EGFRL858R/T790M and EGFRL858R/T790M/C797S with IC50 values of 9
2-dihydroquinolin-6-yl)oxy]propyl}urea
BNC375 exhibits good CNS-drug like properties and clinical candidate potential
selective inhibitor of intermediate-conductance Ca2+-activated K+channels
BMS-817378 Catalog No.:M23243-C EGFRL858R/T790M and EGFRL858R/T790M/C797S with IC50Description: IC50: 1. 7 nM 15 nM for Met VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility and is functionally linked to the signaling pathway of VEGF, which is widely recognized as a key effector in angiogenesis and cancer progression. BMS 817378 is a potent ATP competitive inhibitor of Met VEGFR2. In vitro: BMS 794833, which is the active